Celldex Therapeutics Presents Positive Data from
- Rapid, profound and durable responses across multiple dosing groups with favorable safety profile observed—positioning barzolimab as a potential...
- Rapid, profound and durable responses across multiple dosing groups with favorable safety profile observed—positioning barzolimab as a potential...
Lead attorney and plaintiff to be present to discuss details of lawsuit filed Monday morning...
Denver, CO, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Intrepid Potash Inc. (NYSE: IPI) plans to release its fourth quarter 2022 financial results on Monday,...
WHY: NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims...
Chatterjee to Assume Role of Chief Legal Officer in 2024...
COLUMBUS, Ohio, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) today issued the following statement in response to an...
Thermo Fisher Scientific, Inc., Illumina, Inc., Invitae Corporation, F. Hoffmann-La Roche Ltd., MedGenome, CENTOGENE N.V., Myriad Genetics, Inc., eviCore...